News
What are the benefits and risks of vaginal lasers for treating stress urinary incontinence in women?
We found nine studies involving a total of 689 women with stress urinary incontinence. Nine studies compared vaginal lasers to either sham or lubricant, and one study compared vaginal lasers to ...
دانشمندان، سیاستگذاران و تصمیمگیرندگان برای شواهدی که میتوانند به آنها تکیه کنند، به ما مراجعه میکنند. بیاموزید که چرا ...
Transcranial laser therapy (low-level light therapy applied to the head) does not reduce the number of people who die or have moderate to severe disability at 90 days after ischaemic stroke (where ...
- Corticosteroids may decrease transient inflammatory reaction events associated with antibiotic treatment of leptospirosis infection, although the certainty of this evidence is very uncertain.
Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...
Vitamin C supplementation may help reduce the risk of pregnancy complications such as pre-eclampsia, intrauterine growth restriction and maternal anaemia. There is a need to evaluate the efficacy and ...
Cambiamos vidas y sistemas El 75 % de las nuevas guías de la Organización Mundial de la Salud de los últimos 5 años citan al menos una revisión Cochrane. Leer acerca de nuestro impacto.
Review question Which treatments are effective for rosacea? Background Rosacea is a common skin condition causing flushing, redness, red pimples and pustules on the face, and should not be confused ...
Znanstvenici, kreatori politika i donositelji odluka obraćaju nam se za dokaze na koje se mogu osloniti. Saznajte zašto su ...
Para saintis, pembuat dasar dan pembuat keputusan merujuk kepada kami untuk bukti yang boleh dipercayai. Ketahui sebab bukti ...
Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas of global health: dengue prevention and neonatal mortality reduction.
Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas of global health: dengue prevention and neonatal mortality reduction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results